VERTEX PHARMACEUTICALS INC / MA Investing Cash Flow 2008-2026 | VRTX
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is VERTEX PHARMACEUTICALS INC / MA's current investing cash flow?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual investing cash flow for 2025 was $-945.4M, a 74.92% increase from 2024. VERTEX PHARMACEUTICALS INC / MA investing cash flow for the quarter ending March 31, 2026 was $-431.9M.
What was VERTEX PHARMACEUTICALS INC / MA's investing cash flow in 2024?
VERTEX PHARMACEUTICALS INC / MA annual investing cash flow for 2024 was $-3.77B, a 20.00% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's investing cash flow in 2023?
VERTEX PHARMACEUTICALS INC / MA annual investing cash flow for 2023 was $-3.14B, a 878.42% decline from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$99.4M
→
FY2025
$-945.4M
080910111213141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-945.4M | +74.9% | 10-K |
| FY2024 | $-3.77B | -20.0% | 10-K |
| FY2023 | $-3.14B | -878.4% | 10-K |
| FY2022 | $-321.1M | +5.8% | 10-K |
| FY2021 | $-340.9M | -443.0% | 10-K |
| FY2020 | $99.4M | +108.0% | 10-K |
| FY2019 | $-1.24B | -511.1% | 10-K |
| FY2018 | $-202.2M | +58.2% | 10-K |
| FY2017 | $-483.3M | -1043.3% | 10-K |
| FY2016 | $51.2M | -80.9% | 10-K |
| FY2015 | $268.9M | +227.8% | 10-K |
| FY2014 | $82.0M | +172.9% | 10-K |
| FY2013 | $-112.6M | +73.6% | 10-K |
| FY2012 | $-425.8M | -300.5% | 10-K |
| FY2011 | $212.4M | +2809.4% | 10-K |
| FY2010 | $7.3M | +101.4% | 10-K |
| FY2009 | $-508.7M | -41.1% | 10-K |
| FY2008 | $-360.6M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →